Saturday, June 30, 2018 8:44:36 PM
Merck partnering in Head and Neck will be their 3rd collaboration agreement with Oncosec.
Bristol Myers' Opdivo in combo with Oncosec in neoadjuvant melanoma means they are getting on board as well finally.....a very good sign.
The multi-gene construct to be announced soon will utilize the latest Oncosec generator and applicators and hopefully take the market by surprise.
Oncosec is setting up for a very strong end of year with PISCES data to be released in the fall. If the results are stellar like the SITC results last year, 2019 will be explosive for the company. Multiple licensing deals will be struck. Oncosec will increase significantly in market cap and hopefully entertain a buyout offer.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM